徐慧芳,陈 琼,刘 茵.2017年河南省食管癌流行现况及2010—2017年变化趋势分析[J].中国肿瘤,2021,30(11):848-854.
2017年河南省食管癌流行现况及2010—2017年变化趋势分析
Incidence and Mortality of Esophageal Cancer in Henan in 2017 and Trend of Changes from 2010 to 2017
中文关键词  修订日期:2021-06-22
DOI:10.11735/j.issn.1004-0242.2021.11.A008
中文关键词:  食管癌  发病率  死亡率  变化趋势  河南
英文关键词:esophageal cancer  incidence  mortality  trend  Henan
基金项目:
作者单位
徐慧芳 郑州大学附属肿瘤医院河南省肿瘤医院河南省肿瘤防控工程研究中心河南省肿瘤预防国际联合实验室 
陈 琼 郑州大学附属肿瘤医院河南省肿瘤医院河南省肿瘤防控工程研究中心河南省肿瘤预防国际联合实验室 
刘 茵 郑州大学附属肿瘤医院河南省肿瘤医院河南省肿瘤防控工程研究中心河南省肿瘤预防国际联合实验室 
摘要点击次数: 1083
全文下载次数: 186
中文摘要:
      摘 要:[目的] 分析2017年河南省食管癌的发病与死亡情况及2010—2017年变化趋势。[方法] 基于符合质量评估标准的数据,结合2017年河南省人口数据,按照城乡和年龄分层,估计2017年河南省食管癌的发病及死亡情况。中国人口标化率(中标率)采用2000年全国人口普查标准人口年龄构成标化,世界人口标化率(世标率)采用Segi’s标准人口年龄构成标化。计算2010—2017年期间食管癌中标发病率和死亡率的年度变化百分比(APC)及平均年度变化百分比(AAPC)。[结果] 据估计,2017年河南省新发食管癌33 860例,死亡25 581例。河南省2017年食管癌发病率为31.28/10万,中标发病率为22.45/10万,世标发病率为22.70/10万,0~74岁累积发病率为2.89%,男女发病率比为1.73∶1。城市和农村地区的食管癌中标发病率分别为17.72/10万和24.55/10万。河南省2017年食管癌死亡率为23.63/10万,中标死亡率为16.23/10万,世标死亡率为16.36/10万,0~74岁累积死亡率为1.91%,男女死亡率比为1.88∶1。城市和农村地区的食管癌中标死亡率分别为11.80/10万和18.18/10万。2010—2017年期间,河南省的食管癌发病率(APC=-4.0%,P<0.001)及死亡率(APC=-3.1%,P<0.001)呈稳定下降趋势。[结论] 河南省食管癌疾病负担呈下降趋势,但仍然高于全国平均水平,应针对河南省的食管癌流行特点制定有效的防控措施,减轻其健康危害。
英文摘要:
      Abstract:[Purpose] To estimate the incidence and mortality of esophageal cancer in Henan Province in 2017 and the trend of changes from 2010 to 2017. [Methods] Based on the qualified cancer registry data and population data of Henan Province in 2017, the incidence and mortality of esophageal cancer in Henan Province were estimated by areas and gender. Age-standardized incidence and mortality rates were adjusted by Chinese standard population in 2000(ASIRC, ASMRC) and Segi’s world population(ASIRW, ASMRW). The annual percentage change(APC) and average annual percentage change(AAPC) of ASIRC and ASMRC from 2010 to 2017 were analyzed. [Results] In 2017, the estimated esophageal cancer new cases and deaths were 33 860 and 25 581, respectively in Henan Province. The crude incidence was 31.28/105. The ASIRC and ASIRW were 22.45/105 and 22.70/105, respectively. The cumulative incidence (0~74 years old) was 2.89%. The incidence ratio of male to female was 1.73∶1. The ASIRC in urban and rural areas was 17.72/105 and 24.55/105, respectively. In 2017, the crude mortality of esophageal cancer was 23.63/105. The ASMRC and ASMRW were 16.23/105 and 16.36/105, respectively. The cumulative mortality rates(0~74 years old) were 1.91%. The mortality ratio of male to female ratio was 1.88∶1. The ASMRC in urban and rural areas was 11.80/105 and 18.18/105, respectively. The incidence(APC=-4.0%,P<0.001) and mortality(APC=-3.1%, P<0.001) of esophageal cancer in Henan showed a steady downward trend from 2010 to 2017. [Conclusion] The disease burden of esophageal cancer in Henan Province is higher than that in China. Effective prevention and control measures should be established and applied according to the epidemiological distribution in Henan Province to reduce its health hazards.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器